Heracross δ (Reverse Holofoil)
Dragon Frontiers · #3
Overview
Legality, special rules, and flavor text
Format legality
- StandardNot Legal
- UnlimitedLegal
- ExpandedNot Legal
- Gym Leader ChallengeNot Legal
Card details
Printing, type line, and catalog data
Identity & printing
- Card ID
- ex15-3--reverseHolofoil
- Name
- Heracross δ (Reverse Holofoil)
- Number
- 3
- Printed number
- 3/101
- Rarity
- Rare Holo
- Rarity code
- ★H
- Variant
- Reverse Holofoil
Type line & stats
- Supertype
- Pokémon
- Subtypes
- Basic, Delta Species
- Types
- Fire
- HP
- 70
Set, artist & references
- Retreat cost
- 1
- Artist
- Mitsuhiro Arita
- Language
- English
- Set name
- Dragon Frontiers
- Game name
- Pokémon
Battle
Abilities, attacks, weakness & resistance
Abilities
- Poké-Body: Shining Horn
As long as Heracross is the only Pokémon you have in play, your opponent's Basic Pokémon can't attack.
Attacks
- Dig DeepCost: 1
Search your discard pile for an Energy card, show it to your opponent, and put it into your hand.
- Extra Claws30+Cost: 2
If the Defending Pokémon is Pokémon-ex, this attack does 30 damage plus 20 more damage.
Weaknesses
- Fire ×2
eBay market prices
Sold and listed medians — tap a grade for comps
More conditions (eBay)
Add LP / MP / HP / DMG or a slab grade (PSA 8, ACE 9, BGS 9.5, …). Everyone sees the same prices; scheduled refreshes include these variants.
Listed on marketplace
Vendors currently listing this card/product on our marketplace. Click through to view or purchase (purchase flow coming soon).
No marketplace listings for this card right now.
More in this set
Other cards from Dragon Frontiers
Mew ☆ δ (Holofoil)#101
Mew ☆ δ (Dylan Lefavour)#101
Charizard ☆ δ (Holofoil)#100
Tyranitar ex δ (Holofoil)#99
Salamence ex δ (Holofoil)#98
Rayquaza ex δ (Tom Roos)#97
Rayquaza ex δ (Holofoil)#97
Latios ex δ (Holofoil)#96
Latias ex δ (Holofoil)#95
Kingdra ex δ (Holofoil)#94
Gardevoir ex δ (Holofoil)#93
Flygon ex δ (Jun Hasebe)#92
Comments
Share your thoughts on this card — condition, value, pull rates, etc.
to comment.
No comments yet. Be the first to share your thoughts.